Founded as a spin-off from the University of Turin, RASGenix is driving the development of groundbreaking pharmaceutical technologies for drug discovery in oncology. With a focus on RAS-dependent diseases, our company offers a comprehensive range of customisable preclinical services backed by decades of academic and translational research. Our global team of experts delivers precision-driven solutions tailored to pharmaceutical and biotechnology companies worldwide, shaping the future of oncological targeted therapies.
Company Details
- Founded
- 2024
- Address
- Via Nizza, 52, Turin,piedmont 10126,italy
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- http://www.rasgenix.com
- HQ
- Turin, Piedmont
Rasgenix Srl Questions
Rasgenix Srl's website is http://www.rasgenix.com
Rasgenix Srl's LinkedIn profile is https://it.linkedin.com/company/rasgenix-srl
Rasgenix Srl's industry is
Biotechnology Research
Rasgenix Srl's top competitors are
Ager_tech,
Xspline S.p.a.,
Inta Systems,
Exolab Italia,
Small Rnas In Cancer Progression,
Galatea Biotech,
Euremab,
Rosebio,
Evobiotech,
Klasther Biopharma.
Rasgenix Srl's categories are Biotechnology Research
Rasgenix Srl's founding year is 2024
